Efficacy and safety of rituximab on lung and skin involvement in systemic sclerosis: a systematic review and metaanalysis

Safety and efficacy of Rituximab in systemic sclerosis: A systematic review and meta-analysis

(2020) Rui Tang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

(2019) Muriel Elhai et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

(2019) Satoshi Ebata et al.   JOURNAL OF DERMATOLOGY

Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review

(2018) Mathilde Thiebaut et al.   AUTOIMMUNITY REVIEWS

OUP accepted manuscript

(2018)   RHEUMATOLOGY

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

(2017) Dimitrios Daoussis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis

(2017) Karin Melsens et al.   ACTA CLINICA BELGICA

Systemic sclerosis

(2015) Amber Young et al.   CURRENT OPINION IN RHEUMATOLOGY

Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis

(2015) Silvia L. Bosello et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

(2014) Suzana Jordan et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen

(2014) FC Moazedi-Fuerst et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Mortality and survival in systemic sclerosis: Systematic review and meta-analysis

(2014) Manuel Rubio-Rivas et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Rituximab for Non-Hodgkin's Lymphoma: A Story of Rapid Success in Translation

(2013) Andrew M. Harrison et al.   CTS-Clinical and Translational Science

Two-year Results of an Open Pilot Study of a 2-treatment Course with Rituximab in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement

(2012) V. SMITH et al.   JOURNAL OF RHEUMATOLOGY

The Pathogenesis of Systemic Sclerosis

(2011) Tamiko R. Katsumoto et al.   Annual Review of Pathology-Mechanisms of Disease

Biologic Therapy for Systemic Sclerosis: A Systematic Review

(2010) V. PHUMETHUM et al.   JOURNAL OF RHEUMATOLOGY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

(2010) Silvia Bosello et al.   ARTHRITIS RESEARCH & THERAPY

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

(2009) Robert Lafyatis et al.   ARTHRITIS AND RHEUMATISM

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

(2009) Dimitrios Daoussis et al.   RHEUMATOLOGY

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

(2008) V Smith et al.   ANNALS OF THE RHEUMATIC DISEASES